Abstract: A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5.alpha.-reductase and their preparation is disclosed.
Type:
Grant
Filed:
September 20, 1994
Date of Patent:
November 26, 1996
Assignee:
Eli Lilly and Company
Inventors:
Kevin L. Haehl, Thomas J. Kress, James P. Wepsiec
Abstract: This invention provides novel, optionally substituted tetrahydropyridoindoles which are useful serotonergic agents for the treatment of central nervous system disorders.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
October 8, 1996
Assignee:
Eli Lilly and Company
Inventors:
Jeremy Gilmore, Peter T. Gallagher, Martin V. Miles, William M. Owton, Colin W. Smith